{
  "cik": 1464521,
  "cik_padded": "0001464521",
  "entityName": "Heartflow, Inc.",
  "fiscal_years": [
    {
      "accn": "0001464521-26-000042",
      "filed": "2026-03-18",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 5025000.0,
        "cash": 44776000.0,
        "cost_of_revenue": 40837000.0,
        "eps_diluted": -3.17,
        "free_cash_flow": -59048000.0,
        "gross_profit": 135197000.0,
        "net_income": -116791000.0,
        "operating_cash_flow": -54023000.0,
        "operating_income": -64066000.0,
        "revenue": 176034000.0,
        "stockholders_equity": 300647000.0,
        "total_assets": 359452000.0,
        "total_liabilities": 58805000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "gross_margin": 0.7680164059215834,
        "leverage": 0.19559483380841985,
        "net_margin": -0.6634570594317007,
        "operating_margin": -0.363941056841292,
        "revenue_growth_yoy": 0.39922739412438,
        "roa_avg2y": -0.4885058432812722,
        "roa_period_end": -0.32491403581006645,
        "roe_avg2y": 0.41797876661709943,
        "roe_period_end": -0.38846554264635935
      }
    },
    {
      "accn": "0001464521-26-000042",
      "filed": "2026-03-18",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 4357000.0,
        "cash": 51367000.0,
        "cost_of_revenue": 31359000.0,
        "eps_diluted": -17.98,
        "free_cash_flow": -73358000.0,
        "gross_profit": 94449000.0,
        "net_income": -96426000.0,
        "operating_cash_flow": -69001000.0,
        "operating_income": -61222000.0,
        "revenue": 125808000.0,
        "stockholders_equity": -859484000.0,
        "total_assets": 118704000.0,
        "total_liabilities": 209622000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "gross_margin": 0.7507392216711178,
        "net_margin": -0.7664536436474628,
        "operating_margin": -0.4866304209589215,
        "revenue_growth_yoy": 0.44318260031660817,
        "roa_period_end": -0.8123230893651435,
        "roe_avg2y": 0.11780473144342744
      }
    },
    {
      "accn": "0001464521-26-000042",
      "filed": "2026-03-18",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "capex": 6105000.0,
        "cash": 122767000.0,
        "cost_of_revenue": 29123000.0,
        "eps_diluted": -25.32,
        "free_cash_flow": -82539000.0,
        "gross_profit": 58051000.0,
        "net_income": -95655000.0,
        "operating_cash_flow": -76434000.0,
        "operating_income": -72914000.0,
        "revenue": 87174000.0,
        "stockholders_equity": -777564000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "gross_margin": 0.665921031500218,
        "net_margin": -1.0972881822561773,
        "operating_margin": -0.8364191157914057,
        "roe_avg2y": 0.1300363511790343
      }
    },
    {
      "accn": "0001464521-26-000042",
      "filed": "2026-03-18",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -693640000.0
      },
      "period_end": "2022-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001464521-26-000042",
    "filed": "2026-03-18",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "3841",
  "sic_description": "Surgical & Medical Instruments & Apparatus",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001464521.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001464521.json"
  },
  "ticker": "HTFL"
}